The construction of a novel prognostic prediction model for glioma based on GWAS-identified prognostic-related risk loci

Jie Wei,Yujie Li,Wenqian Zhou,Xiaoya Ma,Jie Hao,Ting Wen,Bin Li,Tianbo Jin,Mingjun Hu

DOI: https://doi.org/10.1515/med-2024-0895

2024-03-16

Open Medicine

Abstract:Glioma is a highly malignant brain tumor with a grim prognosis. Genetic factors play a role in glioma development. While some susceptibility loci associated with glioma have been identified, the risk loci associated with prognosis have received less attention. This study aims to identify risk loci associated with glioma prognosis and establish a prognostic prediction model for glioma patients in the Chinese Han population. A genome-wide association study (GWAS) was conducted to identify risk loci in 484 adult patients with glioma. Cox regression analysis was performed to assess the association between GWAS-risk loci and overall survival as well as progression-free survival in glioma. The prognostic model was constructed using LASSO Cox regression analysis and multivariate Cox regression analysis. The nomogram model was constructed based on the single nucleotide polymorphism (SNP) classifier and clinical indicators, enabling the prediction of survival rates at 1-year, 2-year, and 3-year intervals. Additionally, the receiver operator characteristic (ROC) curve was employed to evaluate the prediction value of the nomogram. Finally, functional enrichment and tumor-infiltrating immune analyses were conducted to examine the biological functions of the associated genes. Our study found suggestive evidence that a total of 57 SNPs were correlated with glioma prognosis ( p < 5 × 10 −5 ). Subsequently, we identified 25 SNPs with the most significant impact on glioma prognosis and developed a prognostic model based on these SNPs. The 25 SNP-based classifier and clinical factors (including age, gender, surgery, and chemotherapy) were identified as independent prognostic risk factors. Subsequently, we constructed a prognostic nomogram based on independent prognostic factors to predict individualized survival. ROC analyses further showed that the prediction accuracy of the nomogram (AUC = 0.956) comprising the 25 SNP-based classifier and clinical factors was significantly superior to that of each individual variable. We identified a SNP classifier and clinical indicators that can predict the prognosis of glioma patients and established a prognostic prediction model in the Chinese Han population. This study offers valuable insights for clinical practice, enabling improved evaluation of patients' prognosis and informing treatment options.

medicine, general & internal

What problem does this paper attempt to address?

The main problem that this paper attempts to solve is to construct a new prognostic prediction model based on the risk loci related to glioma prognosis identified by genome - wide association studies (GWAS). Specifically, the study aims to:

1. **Identify risk loci related to glioma prognosis**: Through GWAS analysis, identify single - nucleotide polymorphisms (SNPs) related to the prognosis of glioma patients.
2. **Establish a prognostic prediction model**: Use LASSO Cox regression analysis and multivariate Cox regression analysis to construct a prognostic prediction model based on these SNPs.
3. **Develop a scoring system for clinical applications**: Based on independent prognostic factors (such as age, gender, surgery, chemotherapy, etc.), construct a nomogram model to predict the 1 - year, 2 - year, and 3 - year survival rates of patients.
4. **Evaluate the predictive performance of the model**: Through receiver operating characteristic curve (ROC) analysis, evaluate the predictive accuracy of the nomogram model.

### Research Background
Glioma is a highly malignant brain tumor with a poor prognosis. Genetic factors play an important role in the development of glioma. Although some loci related to glioma susceptibility have been discovered, the risk loci related to prognosis have received less attention. Therefore, this study aims to fill this gap and provide valuable insights for clinical practice to improve the prognosis assessment and treatment options of patients.

### Research Methods
1. **GWAS analysis**: Conduct genome - wide association studies on 484 adult glioma patients to identify risk loci.
2. **Cox regression analysis**: Evaluate the relationship between GWAS risk loci and overall survival (OS) and progression - free survival (PFS).
3. **LASSO Cox regression analysis**: Screen out the SNPs that have the greatest impact on glioma prognosis.
4. **Nomogram model construction**: Combine SNP classifiers and clinical indicators to construct a nomogram model to predict individualized survival rates.
5. **Functional enrichment and tumor - infiltrating immune analysis**: Explore the biological functions of related genes and their expression differences in high - risk and low - risk groups.

### Main Results
1. **Identification of SNPs**: The study found 57 SNPs related to glioma prognosis (p < 5×10^-5).
2. **Construction of the prognostic model**: Further screen out 25 SNPs that have the greatest impact on glioma prognosis and construct a prognostic model based on these SNPs.
3. **Determination of independent prognostic factors**: Age, gender, surgery, chemotherapy, and SNP classifiers are determined as independent prognostic risk factors.
4. **Performance of the nomogram model**: The predictive accuracy of the nomogram model is significantly better than that of a single variable (AUC = 0.956).
5. **Functional analysis**: There are significant differences in the expression of 24 genes between the high - risk and low - risk groups, and these genes are mainly enriched in immune - related pathways, such as the p53 - mediated intrinsic apoptosis signaling pathway and the Hippo signaling pathway.

### Conclusion
This study successfully identified an SNP classifier and clinical indicators that can predict the prognosis of glioma patients and established a prognostic prediction model in the Chinese Han population. These findings provide valuable references for clinical practice and help improve the prognosis assessment and treatment options of patients.